Innophos Holdings, Inc. (IPHS) Holdings Lifted by Algert Global LLC
Algert Global LLC grew its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 9.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 51,122 shares of the specialty chemicals company’s stock after purchasing an additional 4,296 shares during the period. Algert Global LLC’s holdings in Innophos were worth $2,270,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in IPHS. Itau Unibanco Holding S.A. acquired a new stake in shares of Innophos during the second quarter worth approximately $144,000. Raymond James & Associates acquired a new stake in shares of Innophos during the second quarter worth approximately $209,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Innophos during the second quarter worth approximately $217,000. Alps Advisors Inc. acquired a new stake in shares of Innophos during the second quarter worth approximately $213,000. Finally, Piedmont Investment Advisors LLC acquired a new stake in shares of Innophos during the second quarter worth approximately $217,000. Institutional investors own 94.16% of the company’s stock.
IPHS stock opened at $24.87 on Friday. The company has a quick ratio of 1.36, a current ratio of 2.79 and a debt-to-equity ratio of 1.01. The company has a market cap of $500.61 million, a P/E ratio of 10.05 and a beta of 1.23. Innophos Holdings, Inc. has a 52 week low of $24.46 and a 52 week high of $50.40.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Friday, November 16th will be issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 7.72%. The ex-dividend date of this dividend is Thursday, November 15th. Innophos’s dividend payout ratio is currently 78.05%.
Several research firms recently commented on IPHS. BidaskClub upgraded shares of Innophos from a “sell” rating to a “hold” rating in a report on Tuesday, September 18th. TheStreet cut shares of Innophos from a “b-” rating to a “c+” rating in a report on Thursday, August 23rd. ValuEngine cut shares of Innophos from a “hold” rating to a “sell” rating in a report on Friday, October 12th. Finally, Zacks Investment Research cut shares of Innophos from a “hold” rating to a “strong sell” rating in a report on Thursday, October 25th.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/innophos-holdings-inc-iphs-holdings-lifted-by-algert-global-llc/2666418.html.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Read More: Conference Calls
Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.